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Masanori Murakami, MD, PHD, Mako Ohshima, MS, Masayuki Kubo, PHD,
Toshiro Kobayashi, MD, PHD, Akihito Mikamo, MD, PHD, Yasuhiro Ikeda, MD, PHD,
Masunori Matsuzaki, MD, PHD, Kimikazu Hamano, MD, PHD
Ube, Yamaguchi, Japan
Objectives The aim of this study was to investigate whether the mobilization and recruitment of bone marrow stem cells
(BMSCs) contribute to cardioprotection in the late phase after ischemic pre-conditioning (IPC).
Background IPC is an innate phenomenon in which brief exposure to sublethal ischemia provides tissue protection from sub-
sequent ischemia/reperfusion (I/R) injury. A delayed cardioprotection also occurs after IPC, but the precise
mechanism is unclear.
Methods IPC was created with 4 cycles of 5-min occlusion and reperfusion of the abdominal aorta in mice. Heart I/R in-
jury was induced by occluding the left anterior descending artery for 30 min immediately (early phase) or 24 h
(late phase) after IPC.
Results Serum vascular endothelial growth factor and stromal cell-derived factor-1 levels were increased significantly 1
and 3 h after IPC, but CD34 and CD34/flk-1 stem cells in the peripheral blood were increased significantly
12 and 24 h after IPC (p  0.05). Compared with the control treatment, both the early and late phases of IPC
protected the heart against I/R injury. However, the recruitment of BMSCs was significantly greater in the heart
when I/R injury was induced in late phase than in the early phase of IPC (p  0.01). Interestingly, the blockade
of the recruitment of BMSCs significantly attenuated the cardioprotective effect of IPC in the late phase (p 
0.01) but did not change in the early phase.
Conclusions Cardioprotection was observed in the early and late phases of IPC; however, the enhanced mobilization and re-
cruitment of BMSCs played an important role in the late phase of IPC. (J Am Coll Cardiol 2009;53:1814–22)
© 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.02.015e
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tschemic pre-conditioning (IPC) is a well-known innate
henomenon in which brief exposure to sublethal ischemia
rovides tissue protection from subsequent ischemia/
eperfusion (I/R) injury in various organs (1). IPC has also
een found to exert systemic effects that result in protection
rom I/R injury of tissues remote from those undergoing
re-conditioning. This is termed “remote IPC” (2). The
rotective effect after IPC occurs in 2 distinct phases (3): the
rom the Department of Surgery and Clinical Science, Department of Medicine and
linical Science, Yamaguchi University Graduate School of Medicine, Ube, Yamagu-
hi, Japan. This work was supported by a Grant-in-Aid for Scientific Research from
he Ministry of Education, Science, Sports, and Culture. Drs. Kamota and Li
ontributed equally to this work.(
Manuscript received September 30, 2008; revised manuscript received February 10,
009, accepted February 16, 2009.arly phase develops rapidly from the time of the initial
schemic insult and lasts for 2 to 3 h, and the late phase
evelops 12 to 24 h after the initial insult and persists for 3
o 4 days (4).
The mechanisms of the 2 phases of IPC are completely
ifferent. The early phase of IPC is generally thought to be
ependent on the immediate release of mediators such as
denosine and bradykinin, the rapid post-translational mod-
fication of pre-existing proteins, and the activation of
omplex second messenger systems (5). Conversely, the late
hase of IPC is thought to be related to the transcriptional
ctivation of various genes including nuclear factor-kappa B
nd signal transducer and activator of transcription-3 that in
urn cause the synthesis of new cardioprotective proteins
5–8). This explains the delayed and prolonged time course
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May 12, 2009:1814–22 IPC and Stem Cellsf protection in the late phase of IPC; however, the precise
echanism of organ protection by IPC remains unclear,
specially in the late phase.
Although the delayed protection of IPC was generally
hought to be mediated by the activation of various transcrip-
ion factors and the synthesis of new proteins, expression of
ome cardioprotective factors has not revealed a second in-
rease peak during the late phase of IPC (9,10). Interestingly,
ecent investigations have found the mobilization of bone
arrow stem cells (BMSCs) into circulating blood, hours to
ays after IPC (11,12). Furthermore, many growth factors
eleased by BMSCs have been found to protect cardiomyocytes
gainst apoptosis (13), and BMSCs are now used effectively for
yocardial repair (14,15). Considering the time needed to
nduce the mobilization of BMSCs into circulating blood, we
ypothesized that the mobilized circulating BMSCs would be
ecruited into the damaged heart and contribute to the delayed
rotection of IPC.
In this study, we monitored the changes in cardioprotec-
ive factors and the mobilization of BMSCs after remote
PC. Then, with a heart I/R injury model, we investigated
hether the mobilized BMSCs were recruited into the heart
nd whether they contributed to cardioprotection, especially
n the late phase of IPC.
ethods
nimals. We obtained male C57BL/6 mice and Wister
ats from Japan SLC (Shizuoka, Japan). Green fluorescent
rotein (GFP)-transgenic mice were kindly provided by
asaru Okabe (16). All experiments were approved by the
nstitutional Animal Care and Use Committee of our
niversity.
one marrow transplantation (BMT). BMT was per-
ormed as described previously (17). Briefly, after lethal
rradiation (10 Gy), each C57BL/6 mouse received intrave-
ous injection with 5 106 bone marrow mononuclear cells
ollected from GFP-transgenic mice. These chimera mice
ere studied 8 weeks after BMT, and the GFP-positive
GFP) circulating leukocytes were checked by flow cy-
ometry (93.6  2.1%).
emote IPC and heart I/R injury models. A remote IPC
odel was established in mice as described previously (18).
riefly, we performed a laparotomy and exposed the ab-
ominal aorta above the bifurcation. Remote IPC was
nduced by 4 cycles of 5-min occlusion followed by 5-min
eperfusion of the abdominal aorta. Control mice received
ham laparotomy with exposure of the abdominal aorta.
Heart I/R injury was induced in the BMT chimera mice
mmediately after IPC (early IPC group), 24 h after IPC
late IPC group), or immediately after sham laparotomy
control group). Briefly, after general anesthesia and tracheal
ntubation, the mice were artificially ventilated with room
ir. We performed a left thoracotomy and occluded the left
nterior descending artery for 30 min with an 8-0 polypro-
ylene suture (19), followed by reperfusion. sonitoring the changes in
lasma cytokines and circulat-
ng BMSCs after IPC. After 1,
, 6, 12, 24, 48, and 72 h of IPC,
he mice were killed, and blood
amples were collected. We mea-
ured the plasma concentrations
f stromal cell-derived factor
SDF)-1 and vascular endo-
helial growth factor (VEGF)
ith mouse SDF-1 and VEGF
nzyme-linked immunosorbent
ssay kits (R&D Systems, Inc.,
inneapolis, Minnesota). Mono-
uclear cells were separated from
he blood samples by gradient
entrifugation. Cells were stained
ith rabbit antimouse flk-1 poly-
lonal antibody (Santa Cruz Bio-
echnology, Inc., Santa Cruz,
alifornia), followed by FITC-
onjugated second antibody. Af-
er washing, cells were also
tained with PE-conjugated rat
ntimouse CD34 monoclonal
ntibody (eBioscience Inc., San
iego, California). Respective
sotype controls were used as a
egative control. Quantitative
ow cytometry analysis was done with a FACScan flow
ytometer (Becton Dickinson, Franklin Lakes, New Jersey).
chocardiography. Cardiac function was assessed 1 and 2
eeks after I/R injury by a single observer blinded to the
reatment regimen, with echocardiography with an HDI-
000 ultrasound machine equipped with a 15-MHz probe
Philips Medical Systems, Eindhoven, the Netherlands)
19). After the induction of light general anesthesia, the
earts were imaged 2-dimensionally in long-axis views at
he level of the greatest left ventricular (LV) diameter. This
iew was used to position the M-mode cursor perpendicular
o the LV anterior and posterior walls. The left ventricular
nd-diastolic diameters (LVEDDs) and left ventricular
nd-systolic diameters (LVESDs) were measured from
-mode recordings according to the leading-edge method.
he left ventricular fractional shortening (LVFS) was cal-
ulated as: (LVEDD  LVESD)/LVEDD  100.
istological analysis. Mice from each group were killed 2
eeks after treatment. The hearts were harvested, and frozen
ections were used for histological analysis (19). Hematoxylin-
osin and Azan staining were done to measure the wall
hickness and the fibrosis area of the LV 2 weeks after
reatment. With the image analysis software Image-Pro Plus
Media Cybernetics Inc., Bethesda, Maryland), the mean wall
hickness was measured from 3 equidistant points in the LV
nterior wall, and the area of fibrosis was calculated as the area
Abbreviations
and Acronyms
BMSC  bone marrow
stem cell
BMT  bone marrow
transplantation
GFP  green fluorescent
protein
IPC  ischemic
pre-conditioning
I/R  ischemia/reperfusion
LV  left
ventricle/ventricular
LVEDD  left ventricular
end-diastolic diameter
LVESD  left ventricular
end-systolic diameter
LVFS  left ventricular
fractional shortening
SDF  stromal cell-derived
factor
TUNEL  terminal
deoxynucleotidyl
transferase dUTP nick end
labeling
VE  vascular endothelial
VEGF  vascular
endothelial growth factortained blue divided by the total area of the LV wall. Mea-
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IPC and Stem Cells May 12, 2009:1814–22urements were done in at least 3 separated sections of each
eart, and the averages were used for statistical analysis.
erminal deoxynucleotidyl transferase dUTP nick end
abeling (TUNEL) assay. To study the apoptosis of car-
iomyocytes, 5 mice from each group were killed 1 day after
/R injury. The hearts were harvested, and frozen sections
ere used for analysis. The apoptotic cardiomyocytes were
etected by TUNEL assay with an ApopTag-Red Apopto-
is in situ Detection Kit (CHEMICON International Inc.,
illerica, Massachusetts). Sections were also stained with
=-6-diamidino-2-phenylindole to visualize the nuclei. At
east 20 different fields were selected randomly for counting
rom 3 independent slides of each heart, and the averages
ere used for statistical analysis.
stimation of the recruitment of BMSCs. Histological
etection of the recruitment of BMSCs in the heart was
one 1 day after treatment. Frozen sections were incubated
ith Alexa Fluor 488-conjugated rabbit anti-GFP poly-
lonal antibody (Invitrogen Inc., Carlsbad, California) to
etect the bone marrow-derived GFP cells, and stem cells
ere then identified by staining with PE-conjugated rat
onoclonal antibodies against mouse Sca-1 or c-kit. The
Figure 1 Kinetics of Cardioprotective Factors and Stem Cells in
Enzyme-linked immunosorbent assay (ELISA) measurement showed remarkably inc
factor (VEGF) (B) 1 and 3 h after ischemic pre-conditioning (IPC), which returned to
cells (D) in the peripheral blood increased from 12 h after IPC and peaked at 24 h
a duplicative assay.MSCs were counted in at least 10 different fields from 3
ndependent slides of each heart, and the averages were used
or statistical analysis.
The recruitment of BMSCs was also estimated by quan-
itative flow cytometry, as described previously (20). Briefly,
e extracted the hearts 1 day after I/R injury in each group
n  3). The myocardium from each heart was minced and
hen digested in 0.1% collagenase. We collected all of the
solated cells from each heart and incubated with PE-
onjugated rat monoclonal antibodies against mouse Sca-1
r c-kit. Quantitative flow cytometry analysis was done as
escribed in the preceding text.
ifferentiation of BMSCs. The differentiation of BMSCs
n the heart was detected 2 weeks after I/R injury. The
MSCs were stained with Alexa Fluor 488-conjugated
abbit anti-GFP polyclonal antibody (Invitrogen Inc.). The
yocardial differentiation of BMSCs was identified by
mmunostaining with goat antitroponin I polyclonal anti-
ody, followed by Texas Red-conjugated second antibody,
nd endothelial differentiation of BMSCs was identified by
E-conjugated goat antivascular endothelial (VE)-cadherin
olyclonal antibody (Santa Cruz Biotechnology Inc.).
Peripheral Blood After IPC
plasma stromal cell-derived factor (SDF)-1 (A) and vascular endothelial growth
aseline level from 6 h onward. Conversely, CD34 cells (C) and CD34/flk-1
at each time point were derived from 3 to 5 mice, and ELISA was performed bythe
reased
the b
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May 12, 2009:1814–22 IPC and Stem Cellsoculture of adult cardiomyocytes and BMSCs. To con-
rm the cardioprotective effect of BMSCs, we cocultured adult
ardiomyocytes with BMSCs as described previously (13).
dult cardiomyocytes were isolated from 13-week-old Wister
ats. Freshly isolated cardiomyocytes were placed on laminin-
oated culture slides, and cocultured with or without bone
arrow mononuclear cells. After 7 days of cultivation, the
poptotic cardiomyocytes were detected by TUNEL assay with
poptosis Detection Kits (R&D Systems, Inc.).
ntervention study by blocking the recruitment of BMSCs
nto I/R injured heart. To confirm that the cardioprotec-
ive effect of IPC is related directly to the mobilization and
ecruitment of BMSCs, an intervention study was per-
ormed by blocking the recruitment of BMSCs into the I/R
njury heart after IPC. The blockade of the recruitment of
MSCs was done by the antibody disruption of the SDF-
/CXCR4 axis as described previously (17), and a nonspe-
ific action of antibody was controlled by the administration
f the same dose of nonspecific immunoglobulin. Briefly,
ice were given an intraperitoneal injection with 10 g/kg
abbit antimouse CXCR4 polyclonal antibody (Cell Science
nc., Canton, Massachusetts) or nonspecific immunoglob-
lin 2 h before IPC (early IPC), 22 h after IPC (late IPC),
r 2 h before sham laparotomy (control). The I/R injury was
nduced immediately after IPC (early IPC), 24 h after IPC
late IPC), or immediately after sham laparotomy (control).
ll surgical procedures, cardiac function measurement, and
Figure 2 Echocardiographic Assessment of Cardiac Function
(A) Representative M-mode echocardiograms in each group, 2 weeks after ischem
(B), left ventricular end-systolic diameters (LVESDs) (C), and left ventricular fract
mic pre-conditioning.istological analysis were done as described in the preceding
ext.
tatistical analysis. All data are presented as mean  SD.
tatistical significance between 2 groups was determined by the
-tailed unpaired Student t test, and among groups it was
etermined by a 1-way analysis of variance followed by Bon-
erroni or Scheffe’s post-hoc test with the StatView software
version 5.0, SAS Institute, Cary, North Carolina). Differences
ere considered statistically significant when p  0.05.
esults
PC increased cardioprotective factors in the early phase
ut enhanced mobilization of BMSCs in the late phase.
schemic pre-conditioning induced a 4-fold increase in
lasma SDF-1 compared with the control, 1 and 3 h after
PC (p  0.005) (Fig. 1A). Similarly, the level of plasma
EGF was also increased approximately 6-fold that of the
ontrol 1 h after IPC (p  0.005) (Fig. 1B). However, the
DF-1 and VEGF had returned to almost the baseline
evels 6 h after IPC and had not re-increased 12, 24, 48, or
2 h after IPC (Figs. 1A and 1B).
The CD34 and CD34/flk-1 stem cells in the periph-
ral blood were not higher in the early phase of IPC than in the
ontrol. Conversely, IPC induced an increase of CD34 and
D34/flk-1 stem cells in the peripheral blood at 12 h, and
his increase peaked 24 h after IPC (Figs. 1C and 1D).
erfusion (I/R) heart injury. The left ventricular end-diastolic diameters (LVEDDs)
hortening (D) were measured 1 and 2 weeks after I/R heart injury. IPC  ische-ia/rep
ional s
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IPC and Stem Cells May 12, 2009:1814–22arly and late phases of IPC protected the heart against
/R injury. Echocardiography showed obviously better wall
otion of the LV anterior wall in the early and late IPC
roups than in the control group (Fig. 2A). Although the
VEDDs did not differ among the groups (Fig. 2B), the
VESDs were significantly lower in both the early and late
PC groups than in the control group, 1 and 2 weeks after
/R injury (p  0.001) (Fig. 2C). The LVFS% was also
ignificantly higher in the early and late IPC groups than in
he control group, 1 and 2 weeks after I/R injury (p 
.001) (Fig. 2D).
Histological analysis revealed that the thickness of the
V anterior wall did not differ significantly among groups
Fig. 3A). However, there was significantly less fibrosis of
he LV in both the early and late IPC groups than in the
ontrol group 2 weeks after I/R injury (p  0.005) (Fig.
B). Furthermore, TUNEL staining analysis showed
ewer apoptotic cells in the early and late IPC groups
han in the control group 1 day after I/R injury (p 
.001) (Fig. 3C). All of these findings indicated that
Figure 3 Histological Examinations
Although the left ventricular wall thickness did not differ among the groups (A, righ
ischemic pre-conditioning (IPC) groups than in the control group (B, right) by Azan
transferase dUTP nick end labeling (TUNEL) assessment of apoptotic cells reveale
group (arrows in left images show representative TUNEL-positive apoptotic cell froemote IPC could protect the heart against I/R injury in
oth the early and late phases.
nhanced recruitment of BMSCs to the I/R injured
eart in the late phase of IPC. Immunostaining analysis
howed that the BMSCs were localized mainly in the risk
rea after I/R injury, although very few of the BMSCs were
lso observed in the area without I/R injury. By quantitative
ounting, we found that the early and late IPC groups had
significantly higher number of bone marrow-derived
FP/Sca-1 (Fig. 4A) and GFP/c-kit (Fig. 4B)
tem cells in the risk area of the I/R injured heart than the
ontrol group without remote IPC. Furthermore, the re-
ruitment of GFP/c-kit and GFP/Sca-1 BMSCs
as approximately 2-fold higher in the late IPC group than
n the early IPC group (p  0.05) (Figs. 4A and 4B).
By quantitative flow cytometry analysis, we confirmed
hat the bone marrow-derived GFP/Sca-1 (Fig. 4C)
nd GFP/c-kit (Fig. 4D) stem cells were also approxi-
ately 2- to 3-fold higher in the late IPC group than in the
arly IPC group.
antitative analysis revealed significantly fewer fibrotic areas in the early and late
ng 2 weeks after ischemia/reperfusion injury. (C) Terminal deoxynucleotidyl
ificantly fewer apoptotic cells in the early and late IPC groups than in the control
control group, scale bar  20 m). DAPI  4=-6-diamidino-2-phenylindole.t), qu
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May 12, 2009:1814–22 IPC and Stem Cellsifferentiation of BMSCs after recruitment in the I/R
njured heart. We observed positive expression of the
FP cells to the endothelial-specific marker of VE-
adherin in the heart 2 weeks after I/R injury (Fig. 5A).
urthermore, we also found occasional troponin-I positive
FP cells in the heart 2 weeks after I/R injury (Fig. 5A).
hese findings indicated that BMSCs could be differenti-
ted into myocytes and endothelial cells.
ardioprotective effect of BMSCs through paracrine
echanisms. There were significantly fewer TUNEL-
ositive cardiomyocytes 7 days after coculture with BMSCs than
he cultivation of cardiomyocytes only (p  0.01) (Fig. 5B).
his indicated that BMSCs could protect cardiomyocytes
gainst apoptosis through paracrine mechanisms.
ardioprotective effect was attenuated by blocking the
ecruitment of BMSCs in the late phase but was not in
he early phases of IPC. The LVFS% was significantly
ower in the mice that received anti-CXCR4 antibody injec-
ions than in those that received nonspecific immunoglobulin 1
nd 2 weeks after I/R injury when the I/R heart injury was
nduced in the late phase of IPC (late IPC group) (p  0.01)
Figure 4 The Recruitment of Bone Marrow Stem Cells Into the
Histological analysis revealed that the bone marrow-derived Sca-1/green fluores
late ischemic pre-conditioning (IPC) group than in the early IPC and control groups
Quantitative flow cytometry also revealed that the bone marrow-derived GFP/Sca
than in the early IPC and control groups. HPF  high power field; I/R  ischemia/Fig. 6A, right). However, when the I/R heart injury was Bnduced in the early phase of IPC (early IPC group) or sham
aparotomy (control group) (Fig. 6A, left), the LVFS% was not
ignificantly different between the injection of anti-CXCR4
ntibody and nonspecific immunoglobulin. Compared with
onspecific immunoglobulin, histological analysis also showed
hat the administration of anti-CXCR4 antibody increased
ignificantly the fibrotic area of the LV in the late IPC group
p 0.01) (Fig. 6B), but it did not change in the early IPC and
ontrol groups 2 weeks after I/R injury (Fig. 6B). Furthermore,
uantitative counting showed that the injection of anti-
XCR4 antibody significantly decreased the GFP/Sca-1
nd GFP/c-kit stem cells (p 0.01) (Figs. 6C and 6D) in
he heart 24 h after I/R injury in both early and late IPC
roups. All data suggested that the inhibition of the recruit-
ent of BMSCs by antibody disruption attenuated specifically
he cardioprotective effects in the late phase of IPC but not in
he early phase of IPC.
iscussion
apid developments in stem cell research have revealed that
t 1 Day After I/R Injury
otein (GFP) (A) and c-kit/GFP (B) stem cells were significantly higher in the
ages show representative positive-stained stem cells; scale bars  50 m).
) and GFP/c-kit (D) stem cells were significantly higher in the late IPC group
sion.Hear
cent pr
(left im
-1 (C
reperfuMSCs can protect cardiomyocytes against apoptosis and
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IPC and Stem Cells May 12, 2009:1814–22epair the damaged heart (13–15,21–23). It is well known
hat ischemic stimulation and many IPC-induced factors,
uch as VEGF, erythropoietin, and SDF-1, will improve
he mobilization of BMSCs into peripheral blood (9,24,25).
everal recent investigations have also demonstrated an
ncrease of circulating BMSCs after IPC (11,12). More
nterestingly, in clinical stem cell therapy, a technique of
epetitive balloon dilations (brief exposure to ischemia) that
s used for intracoronary cell delivery has been found to
acilitate the transfer of BMSCs (14,15). All of these
uggested a potential relationship between IPC and BMSCs.
hus, we investigated whether the beneficial effects of IPC
re related to the mobilization and the recruitment of
MSCs, especially in the late phase.
By monitoring the kinetics of stem cells and various
ardioprotective factors, we observed a distinct increase of
tem cells in the peripheral blood from 12 to 72 h after IPC,
ut SDF-1 and VEGF in plasma increased 1 and 3 h after
PC. The phase-specific kinetics of the stem cells and
ardioprotective factors suggested the release of various
actors would account for most of the cardioprotection in
Figure 5 Mechanisms of BMSCs for Cardioprotection
(A) Immunostaining analysis revealed a few GFP cells in the heart with positive
the myocyte specific marker, troponin-I, 2 weeks after I/R injury. (B) In vitro cocult
positive apoptotic cardiomyocytes (arrow in left images) were significantly lower in
alone (CMC). Data are representative of 6 independent experiments. Abbreviationshe early phase of IPC, but the delayed cardioprotection of TPC might be related to the mobilization and recruitment of
tem cells rather than the up-regulation of some cardiopro-
ective factors.
To further examine our hypothesis, we conducted in vivo
tudies by inducing I/R injury in the heart at different
imings after IPC. Remote IPC by transient skeletal
uscle ischemia did not affect the heart directly, which
nabled us to investigate the beneficial effects of IPC on
he heart and the mechanisms responsible at different
imings. As expected, both the early and late phases of
PC afforded cardioprotection against I/R injury. Inter-
stingly, the recruitment of BMSCs in the hearts was
pproximately 2-fold higher after the induction of I/R
njury in the late phase than in the early phase of IPC.
his indicated that the induction of I/R heart injury at
ifferent times of IPC would result in different grades of
ecruitment of BMSCs. Our data showed that the mo-
ilization of BMSCs into circulating blood peaked 24 h
fter IPC. This provided a reasonable explanation for
hy the recruitment of BMSCs was enhanced in the
earts subjected to I/R injury in the late phase of IPC.
sion for the endothelial specific marker, vascular endothelial (VE)-cadherin, and
adult cardiomyocytes and bone marrow stem cells (BMSCs) showed that TUNEL-
lture (cardiomyocyte [CMC]  BMSCs) group than the culture of cardiomyocytes
Figures 3 and 4.expres
ure of
cocu
as inhese findings also phenomenally supported a relation-
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May 12, 2009:1814–22 IPC and Stem Cellship between the recruitment of BMSCs and the cardio-
rotection in the late phase of IPC.
It has been reported that the reduction in myocardial
etabolism and energy consumption also contributes to
ardioprotection in the late phase of classical IPC (26).
owever, the metabolic modification should not be the
ain mechanism in the late phase of IPC in this study,
ecause we used a remote IPC model without direct
istribution of the heart before I/R heart injury. Otherwise,
e cannot deny that the up-regulation of some other mole-
ules would also contribute to the delayed cardioprotection
f IPC, because we did not investigate the changes of other
actors extensively, especially in the I/R injured heart.
To determine a causative relationship between the re-
ruitment of BMSCs and the cardioprotection of late phase
PC, we examined the cardioprotective effect of IPC by
Figure 6 Blocking the Recruitment of BMSCs Into the I/R Inju
(A) Compared with the injection of nonspecific immunoglobulin, the administration
(LVFS%) in the mice that had the I/R heart injury induced 24 h after IPC (late IPC,
injury induced immediately after IPC (early IPC, left) or sham laparotomy (control, r
istration of anti-CXCR4 antibody significantly increased the fibrotic area only in the
(C and D) Quantitative histological analysis showed that the GFP/Sca-1 stem
mice that received anti-CXCR4 antibody injection than in the mice that received nolocking the recruitment of BMSCs. We found that the mlockade of the recruitment of BMSCs eliminated almost
ompletely the cardioprotective effects of IPC at the late
hase. However, the cardiac function was not significantly
hanged by the administration of anti-CXCR4 antibody
ither in the early phase of IPC or after sham laparotomy.
his strongly suggests that the recruitment of BMSCs into
he injured heart played an important role for cardioprotec-
ion in the late phase but not in the early phase of IPC.
The mechanisms of BMSCs for cardioprotection in IPC
emain unclear. However, previous studies have reported that
MSCs can protect and repair a damaged heart by inducing
ngiogenesis (14,15,22), differentiating into endothelial cells
nd myocytes to regenerate new vessel and myocardium (22),
s well as other paracrine mechanisms (13,22). However, the
ifferentiation of BMSCs into endothelial cells was relatively
are and slow, and the differentiation of BMSCs into cardio-
eart by Antibody Disruption After IPC
ti-CXCR4 antibody decreased significantly the left ventricular fractional shortening
) but did not change significantly the LVFS% in the mice that had the I/R heart
1 and 2 weeks after I/R injury. (B) Histological analysis showed that the admin-
C group but not in the early IPC group or control group 2 weeks after I/R injury.
C) and GFP/c-kit stem cells (D) in the heart were significantly lower in the
ific immunoglobulin 24 h after I/R injury. Abbreviations as in Figures 2 and 4.red H
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rotect the heart against I/R injury by the production of various
ardioprotective factors, including VEGF, platelet-derived
rowth factor, and insulin-like growth factor-1 (13,22), rather
han repair by the differentiation and maturation of BMSCs.
ur data of coculture of cardiomyocytes with BMSCs also
upported the paracrine mechanisms.
In this study, we used healthy mice and did not estimate
he quality of BMSCs, including their migratory and
roliferation potential. However, diabetes mellitus, hyper-
ipidemia, aging, and many other factors have been found to
ontribute to a functional impairment of BMSCs (28).
herefore, it will be very interesting to investigate whether
he cardioprotective effect of IPC is also an individual
ifference due to different capacities of mobilization and
ecruitment of BMSCs after IPC.
onclusions
e found that IPC can induce the mobilization of BMSCs in
he late phase. These mobilized BMSCs were recruited to the
amaged heart and contributed to protecting the heart against
/R injury. Our results demonstrate for the first time that IPC
nhances the mobilization and recruitment of BMSCs in the
ate phase to protect the heart against I/R injury, which
rovides new insight into the mechanism of late-phase IPC.
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